Provectus Biopharmaceuticals Inc (PVCT)
0.1828
-0.02
(-8.58%)
USD |
OTCM |
Mar 28, 16:00
Provectus Biopharmaceuticals Market Cap: 76.71M for March 28, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
March 28, 2024 | 76.71M |
March 27, 2024 | 83.90M |
March 26, 2024 | 82.65M |
March 25, 2024 | 83.90M |
March 22, 2024 | 79.96M |
March 21, 2024 | 83.07M |
March 20, 2024 | 83.86M |
March 19, 2024 | 82.86M |
March 18, 2024 | 83.90M |
March 15, 2024 | 90.98M |
March 14, 2024 | 84.91M |
March 13, 2024 | 86.74M |
March 12, 2024 | 89.61M |
March 11, 2024 | 85.39M |
March 08, 2024 | 83.38M |
March 07, 2024 | 89.44M |
March 06, 2024 | 71.32M |
March 05, 2024 | 70.63M |
March 04, 2024 | 70.77M |
March 01, 2024 | 66.28M |
February 29, 2024 | 62.38M |
February 28, 2024 | 61.27M |
February 27, 2024 | 60.83M |
February 26, 2024 | 60.29M |
February 23, 2024 | 59.59M |
Date | Value |
---|---|
February 22, 2024 | 60.79M |
February 21, 2024 | 59.57M |
February 20, 2024 | 59.38M |
February 16, 2024 | 58.29M |
February 15, 2024 | 56.95M |
February 14, 2024 | 57.22M |
February 13, 2024 | 55.99M |
February 12, 2024 | 53.99M |
February 09, 2024 | 57.35M |
February 08, 2024 | 54.54M |
February 07, 2024 | 54.39M |
February 06, 2024 | 54.41M |
February 05, 2024 | 53.22M |
February 02, 2024 | 54.29M |
February 01, 2024 | 53.91M |
January 31, 2024 | 51.89M |
January 30, 2024 | 49.50M |
January 29, 2024 | 47.36M |
January 26, 2024 | 43.92M |
January 25, 2024 | 43.97M |
January 24, 2024 | 42.32M |
January 23, 2024 | 43.71M |
January 22, 2024 | 44.51M |
January 19, 2024 | 44.88M |
January 18, 2024 | 41.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
12.31M
Minimum
Mar 20 2020
90.98M
Maximum
Mar 15 2024
32.05M
Average
26.94M
Median
Jul 05 2019
Market Cap Benchmarks
Insmed Inc | 4.029B |
NeuroMetrix Inc | 8.443M |
Intra-Cellular Therapies Inc | 6.699B |
Rhythm Pharmaceuticals Inc | 2.602B |
Amylyx Pharmaceuticals Inc | 193.18M |
Market Cap Related Metrics
Price | 0.1828 |
Earnings Yield | -3.18% |